Delivery Order HHSD200201141276I-HHSD2002011412760001
Award Date 9/29/11
Potential Completion Date 9/28/21
Potential Value $4.3M
Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Cost No Fee
Place of Performance
Gainesville, FL 32611, USA
Solicitation Procedures
Multiple Award, Fair Opportunity
Number Of Offers Received
10
Legislative Mandate
Service Contract Act
National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The University of Florida (UF) Division of Sponsored Research has been awarded a Delivery Order contract by the Centers for Disease Control and Prevention (CDC) worth $3,102,431.80 to conduct a study comparing testing strategies for latent tuberculosis infection (LTBI) patients. The contract is part of the Tuberculosis Epidemiology Studies Consortium, a larger indefinite delivery, indefinite quantity (IDIQ) contract vehicle. The study aims to compare the effectiveness of the tuberculin skin test...
- This federal contract, valued at $3,752,362.88, was awarded by the Centers for Disease Control and Prevention (CDC) to the University of North Texas Health Science Center at Fort Worth (UNTHSC) to conduct a comparative study on tuberculosis (TB) testing methods. The contract is part of the Tuberculosis Epidemiology Studies Consortium, an indefinite delivery contract, and does not have a set-aside designation. Under this task order, UNTHSC is evaluating the performance of the tuberculin skin test...
- Columbia University has been awarded a $3,145,990 delivery order against its $999,990 Other Transaction Agreement with the Centers for Disease Control and Prevention (CDC). The delivery order is for the TBES Consortium to provide research and development services in support of CDC's disease prevention and health promotion objectives. As part of its Other Transaction Agreement vehicle, Columbia University conducts scientific studies for CDC on topics such as infectious diseases, chronic...
- The Centers for Disease Control and Prevention (CDC) awarded a $9,856,205.74 definitive contract to The Medical University of South Carolina (MUSC) for tuberculosis clinical trials and research support. The contract runs from January 1, 2021 to December 31, 2030 and does not have a set-aside designation. The University of Cape Town in South Africa is a major subcontractor, providing pharmacokinetics research support for the trials. This contract is part of the CDC's Tuberculosis Trials...
- Duke University, as prime contractor, is providing clinical research and immunization safety assessment services under a cost-no-fee delivery order valued at $489,565. This award is issued against the prime IDIQ contract held by Duke University from the Centers for Disease Control and Prevention, entitled "Phase I Clinical Trials for Development of Neurotherapeutics", with a potential value of $86 million through September 2028. No set-aside designation was used for this delivery...
- This is a $504,517 firm fixed-price delivery order awarded by the Centers for Disease Control and Prevention (CDC) to Duke University for services related to the RFTOP 2015-009 AR EBOLA requirement. The order is issued under the CDC's Safety and Healthcare Epidemiology Prevention Research Development (SHEPheRD) indefinite delivery, indefinite quantity (IDIQ) contract. The work will be performed in Durham, North Carolina, and the period of performance runs through December 31, 2017. No...
- This federal contract award was issued by the Centers for Disease Control and Prevention (CDC) Office of Acquisition Services to Emory University, a private research institution in Atlanta, Georgia. The $170,704.03 cost-no-fee delivery order is for a project titled "TB Mortality in the U.S.: Epidemiology and Prevention Opportunities." The contract has no set-aside designation and has an ultimate completion date of September 28, 2011. Emory University, through its Office of Sponsored...
- The Centers for Disease Control and Prevention (CDC) awarded Duke University a $2,180,450.00 Indefinite Delivery Indefinite Quantity (IDIQ) contract for the 2023 Clinical Immunization Safety Assessment (CISA) base contract. This cost-no-fee delivery order contract will provide clinical research and immunization safety assessment services to the CDC through September 27, 2026. The contract was awarded on an unrestricted basis, without any set-aside designations. As a prime contractor, Duke...
- This is a definitive contract awarded by the Centers for Disease Control and Prevention (CDC) to the Denver Health and Hospital Authority, doing business as Denver Health, to provide tuberculosis trials and consortium services over a 10-year period. The contract has a ceiling value of $3,780,225.28 and was awarded on January 1, 2021, with an ultimate completion date of December 31, 2030. The contract requires Denver Health to participate in clinical research studies on the treatment,...
- This federal contract award was issued by the Centers for Disease Control and Prevention (CDC) to Duke University for the "LEAD SITE OPTIONAL TASK 1: BABIES COVID-19 VACCINATION" as a Delivery Order under the existing Clinical Immunization Safety Assessment (CISA) indefinite delivery indefinite quantity (IDIQ) contract vehicle. The contract has a ceiling value of $970,063.00 and a period of performance through December 28, 2025. Duke University, a private university and non-profit...